PCMA: CBO Warns Public Disclosure of Drug-Pricing Information Could Increase Medicare Costs by Billions of Dollars

U.S. Newswire, March, 2007

To: POLITICAL EDITORS

Contact: Phil Blando, 1-202-207-3614, or Charles Cote, 1-202- 207-3605, both of the Pharmaceutical Care Management Association

WASHINGTON, March 13 /PRNewswire-USNewswire/ -- A new analysis from the Congressional Budget Office (CBO) finding that public disclosure of drug- pricing information could potentially increase the cost of the Medicare prescription drug benefit by billions of dollars and facilitate "tacit collusion" among drug manufacturers underscores that one-size-fits-all public disclosure would only serve to increase drug costs and empower drugmakers to charge higher prices, the Pharmaceutical Care Management Association (PCMA) said today.

PCMA is the national association representing America's pharmacy benefit managers (PBMs),...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement